Home › Funds › Decheng Capital LLC › CGON

Decheng Capital LLC position in CGON

CG ONCOLOGY INC · Health Care

Decheng Capital LLC reported holding 6,371,669 shares of CGON (CG ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$451.7M, representing 65.93% of its reported portfolio and ranking #1 among its reported holdings. Decheng Capital LLC has disclosed CGON holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)6.37M sh
Reported value held$451.69M
Portfolio Weight65.93%
First reportedQ1 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Decheng Capital LLC's CGON position evolved

Decheng Capital LLC first disclosed a stake in CGON in Q1 2024 at 5,458,810 shares (US$239.6M). The position peaked in Q2 2026 at 6,371,669 shares, worth US$452.7M. Across 11 filings, Decheng Capital LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 6,371,669 shares valued at US$451.7M.

Quarter by quarter

QuarterSharesValueChange
Q1 2024 5.46M $239.64M New
Q2 2024 5.46M $172.33M Hold
Q3 2024 5.48M $206.72M Hold
Q4 2024 6.37M $182.74M Add
Q1 2025 6.37M $156.04M Hold
Q2 2025 6.37M $165.66M Hold
Q3 2025 6.37M $256.65M Hold
Q4 2025 6.37M $264.55M Hold
Q1 2026 6.37M $431.23M Hold
Q2 2026 6.37M $452.71M Hold
Q3 2026 6.37M $451.69M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGON and 13F data

CGON (CG ONCOLOGY INC) is a Health Care company. 50 other funds we track also report a position in CGON — the largest reported positions include RTW INVESTMENTS, LP (US$605.0M), TCG Crossover Management, LLC (US$260.8M), Foresite Capital Management VI LLC (US$168.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGON

All CGON fund holders →

FAQ

How long has Decheng Capital LLC held CGON?

Decheng Capital LLC has disclosed CGON holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Decheng Capital LLC's current position in CGON?

As of Q3 2026, Decheng Capital LLC holds 6.37M shares of CGON (CG ONCOLOGY INC), valued at $451.69M, representing 65.93% of its reported portfolio and ranking #1.

Has Decheng Capital LLC been buying or selling CGON?

In the latest 13F filing (Q3 2026), Decheng Capital LLC held unchanged its position in CGON. The position peaked in Q2 2026 at 6.37M shares.

Which other funds hold CGON?

Other major institutional holders of CGON include RTW INVESTMENTS, LP, TCG Crossover Management, LLC, Foresite Capital Management VI LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.